Vous êtes ici : Accueil / Valorisation / Publications / 2018

Infos pratiques

Organigramme

Contacts
  • Directeur :

        Pr Eric DELAPORTE

  • Directeur Adjoint :

        Bernard TAVERNE

Accès à la Délégation Régionale IRD-Occitanie (Montpellier)

2018

Mercié P., Arsandaux J., Katlama C., Ferret S., Beuscart A., Spadone C., Duvivier C., Reynes J., Wirth N., Moinot L., Bénard A., Zucman D., Duval X., Molina J.-M., Spire B., Fagard C., Chêne G., Allaguy-Salachy H., Arsandaux J., Aubin H.-J., Bénard A., Bernard-Henry C., Beuscart A., Beuscart C., Borgne A., Bouchaud O., Brahmy C., Breilh D., Cabié A., Cateland C., Chêne G., Cheret A., Couffin-Cadiergues S., Dautzenberg M.-D., Dellamonica P., Denis-Kandel P., Denis-Vatant C., Detilleux M., Dupon M., Duval X., Duvivier C., El Harrar B., Fagard C., Fagnen Sylvaire M. C., Ferret S., Guillermet S., Jacomet C., Jeantils V., Katlama C., Korzek M., Lazaro E., Le Maitre B., Lucht F., Maquet M., Mathieu A., May T., Mercié P., Merigeaud S., Moinot L., Molina J.-M., Morlat P., Naqvi A., Neau D., Perriot J., Pierre-François S., Poizot-Martin I., Quoix E., Rebillard M., Reynes J., Roussillon C., Rosenthal E., Sainte-Marie T., Salmon-Céron D., Schneider L., Simon A., Soussi M., Sotto A., Spadone C., Spire B., Taburet A.-M., Teicher E., Termote M., Trosini-Desert V., Verdon R., Viard J.-P., Vittecoq D., Vray M., Wirth N., Youssi D., et Zucman D.,
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial,
The Lancet HIV. doi: 10.1016/S2352-3018(18)30002-X.

Kassi F. K., Bellet V., Drakulovski P., Krasteva D., Roger F., Valérie B.-T. A., Aboubakar T., Doumbia A., Kouakou G. A., Delaporte E., Reynes J., Yavo W., Menan H. I. E., et Bertout S.,
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast,
J. Med. Microbiol., vol. 67, no 1, p. 87‑96, janv. 2018. doi: 10.1099/jmm.0.000654.

Whittaker C., Walker M., Pion S. D. S., Chesnais C. B., Boussinesq M., et Basáñez M.-G.,
The Population Biology and Transmission Dynamics of Loa loa,
Trends Parasitol., janv. 2018. doi: 10.1016/j.pt.2017.12.003.

Tong C., Suzan-Monti M., Sagaon-Teyssier L., Mimi M., Laurent C., Maradan G., Mengue M.-T., Spire B., Kuaban C., Vidal L., Boyer S., et EVOLCam group,
Treatment interruption in HIV positive patients followed up in Cameroon’s antiretroviral treatment program: individual and healthcare supply related factors (ANRS-12288 EVOLCam survey),
Trop. Med. Int. Health, janv. 2018. doi: 10.1111/tmi.13030.

Ateba Ndongo F., Texier G., Ida Penda C., Tejiokem M. C., Tetang Ndiang S., Ndongo J.-A., Guemkam G., Sofeu C. L., Kfutwah A., Faye A., Msellati P., Warszawski J., et ANRS-Pediacam Study Group,
Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon,
Pediatr. Infect. Dis. J., vol. 37, no 1, p. 78‑84, janv. 2018. doi: 10.1097/INF.0000000000001745.

Boussinesq M.,
A new powerful drug to combat river blindness,
Lancet, janv. 2018. doi: 10.1016/S0140-6736(18)30101-6.

Bouam A., Levasseur A., Bonnet M., Borand L., Van Goethem C., Drancourt M., et Godreuil S.,
Complete Genome Sequence of Mycobacterium sp. Strain 3519A,
Genome Announc, vol. 6, no 4, janv. 2018. doi: 10.1128/genomeA.01565-17.

Grandesso F., Guindo O., Woi Messe L., Makarimi R., Traore A., Dama S., Laminou I. M., Rigal J., de Smet M., Ouwe Missi Oukem-Boyer O., Doumbo O. K., Djimdé A., et Etard J.-F.,
Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger,
Malar. J., vol. 17, no 1, p. 52, janv. 2018. doi: 10.1186/s12936-018-2200-1.

Pion S. D., Boussinesq M., et Kamgno J.,
Treating Onchocerciasis in Regions in Which Loa loa Is Endemic,
N. Engl. J. Med., vol. 378, no 9, p. 871‑872, janv. 2018. doi: 10.1056/NEJMc1716788.

Makinson A., Hayot M., Eymard-Duvernay S., Ribet C., Raffi F., Pialoux G., Zucman D., Poizot-Martin I., Bonnet F., Abgrall S., Tattevin P., Cheret A., Ferry T., Mauboussin J.-M., Marchand L., Rouzaud C., Reynes J., Zins M., Le Moing V., et ANRS EP48 HIV CHEST study Team,
HIV is associated with airway obstruction: a matched controlled study,
AIDS, vol. 32, no 2, p. 227‑232, janv. 2018. doi: 10.1097/QAD.0000000000001691.

D’arc M., Furtado C., Siqueira J. D., Seuánez H. N., Ayouba A., Peeters M., et Soares M. A.,
Assessment of the gorilla gut virome in association with natural simian immunodeficiency virus infection,
Retrovirology, vol. 15, no 1, p. 19, févr. 2018. doi: 10.1186/s12977-018-0402-9.

Eyebe S., Sabbagh A., Pion S.D., Nana-Djeunga H.C., Kamgno J., Boussinesq M. & Chesnais C.B. (2018).
Familial aggregation and heritability of Loa loa microfilaremia.
Clin. Infect. Dis., vol. 66, no 5, p. 751‑757, févr. 2018. doi: 10.1093/cid/cix877.

Desclaux A, Touré A.
Preparation needed for the social dimensions of epidemics in Africa : Experience from a training session in Conakry.
Med Sante Trop, vol. 28, no 1, p. 23‑27, févr. 2018. doi: 10.1684/mst.2018.0749.

Taieb F., Tran Hong T., Ho H. T., Nguyen Thanh B., Pham Phuong T., Viet Ta D., Le Thi Hong N., Ba Pham H., Nguyen L. T. H., Nguyen H. T., Ng
yen T. T., Tuaillon E., Delaporte E., Le Thi H., Tran Thi Bich H., Nguyen T. A., et Madec Y.,
First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam,
PLoS ONE, vol. 13, no 2, p. e0191920, févr. 2018. doi: 10.1371/journal.pone.0191920.

Bouam A., Levasseur A., Bonnet M., Borand L., Van Goethem C., Drancourt M., et Godreuil S.,
Complete Genome Sequence ofMycobacteriumsp. Strain 4858,
Genome Announc, vol. 6, no 7, févr. 2018. doi: 10.1128/genomeA.01604-17.

Galy A., Ciaffi L., Mberyo G. M., Mbouyap P., Abessolo H., Toby R., Essomba F., Lamarre G., Bikié A., Bell O., Koulla-Shiro S., et Delaporte E.,
Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP,
Patient Educ Couns, févr. 2018. doi: 10.1016/j.pec.2018.01.021.

Huerga H., Van Cutsem G., Ben Farhat J., Puren A., Bouhenia M., Wiesner L., Dlamini L., Maman D., Ellman T., et Etard J.-F.,
Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey,
BMC Public Health, vol. 18, no 1, p. 303, févr. 2018. doi: 10.1186/s12889-018-5208-0.

Boussinesq M., Fobi G., et Kuesel A. C.,
Alternative treatment strategies to accelerate the elimination of onchocerciasis,
Int Health, vol. 10, no suppl_1, p. i40‑i48, mars 2018. doi: 10.1093/inthealth/ihx054.

Kamgno J., Nana-Djeunga H. C., Pion S. D., Chesnais C. B., Klion A. D., Mackenzie C. D., Nutman T. B., et Boussinesq M.,
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa,
Int Health, vol. 10, no suppl_1, p. i49‑i53, mars 2018. doi: 10.1093/inthealth/ihx051.

Morquin D., Ologeanu-Taddei R., Koumar Y., et Reynes J.,
Tele-expertise system based on the use of the electronic patient record to support real-time antimicrobial use,
Int J Technol Assess Health Care, p. 1‑7, mars 2018. doi: 10.1017/S0266462318000089.

Bertrand K., Lamy B., De Boutray M., Yachouh J., Galmiche S., Leprêtre P., de Champfleur N. M., Reynes J., Le Moing V., et Morquin D.,
Osteomyelitis of the jaw: time to rethink the bone sampling strategy?,
Eur. J. Clin. Microbiol. Infect. Dis., mars 2018. doi: 10.1007/s10096-018-3219-5.

Bastard M., Sanchez-Padilla E., du Cros P., Khamraev A. K., Parpieva N., Tillyashaykov M., Hayrapetyan A., Kimenye K., Khurkhumal S., Dlamini T., Perez S. F., Telnov A., Hewison C., Varaine F., et Bonnet M.,
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study,
PLoS ONE, vol. 13, no 3, p. e0193491, mars 2018. doi: 10.1371/journal.pone.0193491.

Temfack E., Kouanfack C., Mossiang L., Loyse A., Fonkoua M. C., Molloy S. F., Koulla-Shiro S., Delaporte E., Dromer F., Harrison T., et Lortholary O.,
Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test,
Front Microbiol, vol. 9, p. 409, mars 2018. doi: 10.3389/fmicb.2018.00409.

Colebunders R., Mandro M., Njamnshi A. K., Boussinesq M., Hotterbeekx A., Kamgno J., O’Neill S., Hopkins A., Suykerbuyk P., Basáñez M.-G., Post R. J., Pedrique B., Preux P.-M., Stolk W. A., Nutman T. B., et Idro R.,
Report of the first international workshop on onchocerciasis-associated epilepsy,
Infect Dis Poverty, vol. 7, no 1, p. 23, mars 2018. doi: 10.1186/s40249-018-0400-0.

Fregonese F., Ahuja S. D., Akkerman O. W., Arakaki-Sanchez D., Ayakaka I., Baghaei P., Bang D., Bastos M., Benedetti A., Bonnet M., Cattamanchi A., Cegielski P., Chien J.-Y., Cox H., Dedicoat M., Erkens C., Escalante P., Falzon D., Garcia-Prats A. J., Gegia M., Gillespie S. H., Glynn J. R., Goldberg S., Griffith D., Jacobson K. R., Johnston J. C., Jones-López E. C., Khan A., Koh W.-J., Kritski A., Lan Z. Y., Lee J. H., Li P. Z., Maciel E. L., Galliez R. M., Merle C. S. C., Munang M., Narendran G., Nguyen V. N., Nunn A., Ohkado A., Park J. S., Phillips P. P. J., Ponnuraja C., Reves R., Romanowski K., Seung K., Schaaf H. S., Skrahina A., Soolingen D. van, Tabarsi P., Trajman A., Trieu L., Banurekha V. V., Viiklepp P., Wang J.-Y., Yoshiyama T., et Menzies D.,
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis,
Lancet Respir Med, vol. 6, no 4, p. 265‑275, avril 2018. doi: 10.1016/S2213-2600(18)30078-X.

Moreau K., Clemenceau A., Le Moing V., Messika-Zeitoun D., Andersen P. S., Bruun N. E., Skov R. L., Couzon F., Bouchiat C., Erpelding M. L., van Belkum A., Bossé Y., Duval X., Vandenesch F., French VIRSTA-AEPEI, COFRASA Study Groups, et Danish DANSAB Study Group,
Human Genetic Susceptibility to Native Valve Staphylococcus aureus Endocarditis in Patients With S. aureus Bacteremia: Genome-Wide Association Study,
Front Microbiol, vol. 9, p. 640, avril 2018. doi: 10.3389/fmicb.2018.00640.

Loy D. E., Plenderleith L. J., Sundararaman S. A., Liu W., Gruszczyk J., Chen Y.-J., Trimboli S., Learn G. H., MacLean O. A., Morgan A. L. K., Li Y., Avitto A. N., Giles J., Calvignac-Spencer S., Sachse A., Leendertz F. H., Speede S., Ayouba A., Peeters M., Rayner J. C., Tham W.-H., Sharp P. M., et Hahn B. H.,
Evolutionary history of human Plasmodium vivax revealed by genome-wide analyses of related ape parasites,
Proc.Natl.Acad. Sci. U.S.A., vol. 115, no 36, p. E8450‑E8459, avril 2018. doi: 10.1073/pnas.1810053115.

Godreuil S., Marcy O., Wobudeya E., Bonnet M., et Solassol J.,
Tackling mortality due to childhood tuberculosis,
Lancet Public Health, vol. 3, no 4, p. e165, avril 2018. doi: 10.1016/S2468-2667(18)30049-5.

Laborde-Balen G., Taverne B., Ndour C. T., Kouanfack C., Peeters M., Ndoye I., et Delaporte E.,
The fourth HIV epidemic,
Lancet Infect Dis, vol. 18, no 4, p. 379‑380, avril 2018. doi: 10.1016/S1473-3099(18)30167-1.

Wetzel K. S., Yi Y., Yadav A., Bauer A. M., Bello E. A., Romero D. C., Bibollet-Ruche F., Hahn B. H., Paiardini M., Silvestri G., Peeters M., et Collman R. G.,
Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses,
PLoS Pathog., vol. 14, no 4, p. e1007003, avril 2018. doi: 10.1371/journal.ppat.1007003.

Pradat P., Huleux T., Raffi F., Delobel P., Valantin M.-A., Poizot-Martin I., Pugliese P., Reynes J., Rey D., Hoen B., Cabie A., Bani-Sadr F., Cheret A., Duvivier C., Jacomet C., Fresard A., Hustache-Mathieu L., Cotte L., et Dat’AIDS study Group,
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV,
AIDS, vol. 32, no 8, p. 1077‑1082, mai 2018. doi: 10.1097/QAD.0000000000001789.

Villabona-Arenas C.-J., Eymard-Duvernay S., Aghokeng A. F., Guichet E., Toure-Kane C., Bado G., Koulla-Shiro S., Delaporte E., Ciaffi L., et Peeters M.,
Nucleoside Reverse Transcriptase Inhibitors with reduced predicted activity does not impair second-line therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir,
AIDS Res. Hum.Retroviruses, vol. 34, no 6, p. 477‑480, juin 2018. doi: 10.1089/AID.2017.0290.

Verver S., Walker M., Kim Y. E., Fobi G., Tekle A. H., Zouré H. G. M., Wanji S., Boakye D. A., Kuesel A. C., de Vlas S. J., Boussinesq M., Basáñez M.-G., et Stolk W. A.,
How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control,
Clin. Infect. Dis., vol. 66, no suppl_4, p. S267‑S274, juin 2018. doi: 10.1093/cid/cix1137.

Jacquet J.-M., Peyriere H., Makinson A., Peries M., Nagot N., Donnadieu-Rigole H., Reynes J., et MesConsos Study group,
Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatients,
AIDS, vol. 32, no 9, p. 1165‑1171, juin 2018. doi: 10.1097/QAD.0000000000001830.

Cotte L., Cua E., Reynes J., Raffi F., Rey D., Delobel P., Gagneux-Brunon A., Jacomet C., Palich R., Laroche H., Cabie A., Hoen B., Chidiac C., Pradat P., et Dat’AIDS study Group,
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men,
Liver Int., juin 2018. doi: 10.1111/liv.13922.

Mbala Kingebeni P., Villabona-Arenas C.-J., Vidal N., Likofata J., Nsio-Mbeta J., Makiala-Mandanda S., Mukadi D., Mukadi P., Kumakamba C., Djokolo B., Ayouba A., Delaporte E., Peeters M., Muyembe Tamfum J.-J., et Ahuka Mundeke S.,
Rapid confirmation of the Zaire Ebola Virus in the outbreak of the Equateur province in the Democratic Republic of Congo: implications for public health interventions,
Clin.Infect. Dis., juin 2018. doi: 10.1093/cid/ciy527.

Eron J. J., Orkin C., Gallant J., Molina J.-M., Negredo E., Antinori A., Mills A., Reynes J., Van Landuyt E., Lathouwers E., Hufkens V., Jezorwski J., Vanveggel S., Opsomer M., et AMBER study group,
A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients,
AIDS, vol. 32, no 11, p. 1431‑1442, juill. 2018. doi: 10.1097/QAD.0000000000001817.

Kendall E. A., Brigden G., Lienhardt C., et Dowdy D. W.,
Would pan-tuberculosis treatment regimens be cost-effective?,
Lancet Respir Med, vol. 6, no 7, p. 486‑488, juill. 2018. doi: 10.1016/S2213-2600(18)30197-8.

Atwine D., Bonnet M., et Taburet A.-M.,
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review,
Br J Clin Pharmacol, vol. 84, no 8, p. 1641‑1658, août 2018. doi: 10.1111/bcp.13600.

Orikiriza P., Nansumba M., Nyehangane D., Bastard M., Mugisha I. T., Nansera D., Mwanga-Amumpaire J., Boum Y., Kumbakumba E., et Bonnet M.,
Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting,
Eur. J. Clin. Microbiol. Infect. Dis., vol. 37, no 8, p. 1465‑1473, août 2018. doi: 10.1007/s10096-018-3272-0.

Cames C., Pascal L., Ba A., Mbodj H., Ouattara B., Diallo N.-F., Msellati P., Mbaye N., Sy Signate H., Blanche S., Diack A., et MAGGSEN Cohort Study Group,
Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study,
BMC Infect.Dis., vol. 18, no 1, p. 374, août 2018. doi: 10.1186/s12879-018-3282-7.

Keita A. K., Butel C., Thaurignac G., Diallo A., Nioke T., Traoré F., Koivogui L., Peeters M., Delaporte E., et Ayouba A.,
Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak,
Am. J. Trop. Med. Hyg., vol. 99, no 2, p. 425‑427, août 2018. doi: 10.4269/ajtmh.18-0105.

Desclaux A., Malan M. S., Egrot M., Akindès F., et Sow K.,
Neglected patients, unexpected effects. Ebola virus disease suspected case experience
Sante Publique, vol. 30, no 4, p. 565‑574, août 2018. doi: 10.3917/spub.185.0565.

Kmiec D., Akbil B., Ananth S., Hotter D., Sparrer K. M. J., Stürzel C. M., Trautz B., Ayouba A., Peeters M., Yao Z., Stagljar I., Passos V., Zillinger T., Goffinet C., Sauter D., Fackler O. T., et Kirchhoff F.,
SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue,
PLoS Pathog., vol. 14, no 8, p. e1007269, août 2018. doi: 10.1371/journal.ppat.1007269.

Ioos V., Cordel H., et Bonnet M.,
Alternative sputum collection methods for diagnosis of childhood intrathoracic tuberculosis: a systematic literature review,
Arch. Dis.Child., août 2018. doi: 10.1136/archdischild-2018-315453.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N., Ahuja S. D., Akkerman O. W., Alffenaar J.-W. C., Anderson L. F., Baghaei P., Bang D., Barry P. M., Bastos M. L., Behera D., Benedetti A., Bisson G. P., Boeree M. J., Bonnet M., Brode S. K., Brust J. C. M., Cai Y., Caumes E., Cegielski J. P., Centis R., Chan P.-C., Chan E. D., Chang K.-C., Charles M., Cirule A., Dalcolmo M. P., D’Ambrosio L., de Vries G., Dheda K., Esmail A., Flood J., Fox G. J., Fréchet-Jachym M., Fregona G., Gayoso R., Gegia M., Gler M. T., Gu S., Guglielmetti L., Holtz T. H., Hughes J., Isaakidis P., Jarlsberg L., Kempker R. R., Keshavjee S., Khan F. A., Kipiani M., Koenig S. P., Koh W.-J., Kritski A., Kuksa L., Kvasnovsky C. L., Kwak N., Lan Z., Lange C., Laniado-Laborín R., Lee M., Leimane V., Leung C.-C., Leung E. C.-C., Li P. Z., Lowenthal P., Maciel E. L., Marks S. M., Mase S., Mbuagbaw L., Migliori G. B., Milanov V., Miller A. C., Mitnick C. D., Modongo C., Mohr E., Monedero I., Nahid P., Ndjeka N., O’Donnell M. R., Padayatchi N., Palmero D., Pape J. W., Podewils L. J., Reynolds I., Riekstina V., Robert J., Rodriguez M., Seaworth B., Seung K. J., Schnippel K., Shim T. S., Singla R., Smith S. E., Sotgiu G., Sukhbaatar G., Tabarsi P., Tiberi S., Trajman A., Trieu L., Udwadia Z. F., van der Werf T. S., Veziris N., Viiklepp P., Vilbrun S. C., Walsh K., Westenhouse J., Yew W.-W., Yim J.-J., Zetola N. M., Zignol M., et Menzies D.,
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis,
Lancet, vol. 392, no 10150, p. 821‑834, août 2018. doi: 10.1016/S0140-6736(18)31644-1.

Shete P. B., Boccia D., Dhavan P., Gebreselassie N., Lönnroth K., Marks S., Matteelli A., Posey D. L., van der Werf M. J., Winston C. A., et Lienhardt C.,
Defining a migrant-inclusive tuberculosis research agenda to end TB,
Int. J. Tuberc.Lung Dis., vol. 22, no 8, p. 835‑843, août 2018. doi: 10.5588/ijtld.17.0503.

Grebe E., Welte A., Johnson L. F., van Cutsem G., Puren A., Ellman T., Etard J.-F., Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), et Huerga H.,
Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa,
PLoS ONE, vol. 13, no 9, p. e0203638, sept. 2018. doi: 10.1371/journal.pone.0203638.

Canet G., Dias C., Gabelle A., Simonin Y., Gosselet F., Marchi N., Makinson A., Tuaillon E., Van de Perre P., Givalois L., et Salinas S.,
HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?,
Front Cell Neurosci, vol. 12, p. 307, sept. 2018. doi: 10.3389/fncel.2018.00307.

Garchitorena A., Raza-Fanomezanjanahary E.M., Mioramalala S.A.,  Chesnais C.B., Ratsimbasoa C.A., Ramarosata H., Bonds M.H. & Rabenantoandro H. (2018).
Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
PLoS Negl Trop Dis, vol. 12, no 9, p. e0006780, sept. 2018. doi: 10.1371/journal.pntd.0006780.

Allavena C., Hanf M., Rey D., Duvivier C., BaniSadr F., Poizot-Martin I., Jacomet C., Pugliese P., Delobel P., Katlama C., Joly V., Chidiac C., Dournon N., Merrien D., May T., Reynes J., Gagneux-Brunon A., Chirouze C., Huleux T., Cabié A., Raffi F., et Dat’AIDS study group,
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients,
PLoS ONE, vol. 13, no 9, p. e0203895, sept. 2018. doi: 10.1371/journal.pone.0203895.

Ngom N. F., Faye M. A., Ndiaye K., Thiam A., Ndour C. T., Etard J.-F., Sow P. S., Seydi M., Delaporte E., et Cournil A.,
ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015),
PLoS ONE, vol. 13, no 9, p. e0202984, sept. 2018. doi: 10.1371/journal.pone.0202984.

Tchouwa G. F., Eymard-Duvernay S., Cournil A., Lamare N., Serrano L., Butel C., Bertagnolio S., Mpoudi-Ngole E., Raizes E., Aghokeng A. F., et Members of the EHRICA Study Group,
Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey,
J. Antimicrob.Chemother., vol. 73, no 9, p. 2468‑2474, sept. 2018. doi: 10.1093/jac/dky221.

Coulaud P.-J., Sagaon-Teyssier L., Mrenda B. M., Maradan G., Mora M., Bourrelly M., Keita B. D., Keita A. A., Anoma C., Yoro S.-A. B., Dah T. T. E., Coulibaly C., Mensah E., Agbomadji S., Bernier A., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France),
Trop. Med. Int. Health, vol. 23, no 10, p. 1084‑1091, oct. 2018. doi: 10.1111/tmi.13129.

Migisha R., Dan Nyehangane  null, Boum Y., Page A.-L., Zúñiga-Ripa A., Conde-Álvarez R., Bagenda F., et Bonnet M.,
Prevalence and risk factors of brucellosis among febrile patients attending a community hospital in south western Uganda,
Sci Rep, vol. 8, no 1, p. 15465, oct. 2018. doi: 10.1038/s41598-018-33915-9.

Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P. D., et WHO–UNAIDS Network for HIV Isolation Characterisation,
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis,
Lancet Infect Dis, nov. 2018. doi: 10.1016/S1473-3099(18)30647-9.

Villabona-Arenas C. J., Ayouba A., Esteban A., D’arc M., Mpoudi Ngole E., et Peeters M.,
Noninvasive western lowland gorilla’s health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon,
Ecol Evol, vol. 8, no 22, p. 10698‑10710, nov. 2018. doi: 10.1002/ece3.4478.

Chihana M. L., Huerga H., Van Cutsem G., Ellman T., Wanjala S., Masiku C., Szumilin E., Etard J. F., Davies M.-A., et Maman D.,
Impact of « test and treat » recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries,
PLoS ONE, vol. 13, no 11, p. e0207656, nov. 2018. doi: 10.1371/journal.pone.0207656.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C., Arandjelovic I., Bi L., Beckert P., Bonnet M., Bradley P., Cabibbe A. M., Cancino-Muñoz I., Caulfield M. J., Chaiprasert A., Cirillo D. M., Clifton D. A., Comas I., Crook D. W., De Filippo M. R., de Neeling H., Diel R., Drobniewski F. A., Faksri K., Farhat M. R., Fleming J., Fowler P., Fowler T. A., Gao Q., Gardy J., Gascoyne-Binzi D., Gibertoni-Cruz A.-L., Gil-Brusola A., Golubchik T., Gonzalo X., Grandjean L., He G., Guthrie J. L., Hoosdally S., Hunt M., Iqbal Z., Ismail N., Johnston J., Khanzada F. M., Khor C. C., Kohl T. A., Kong C., Lipworth S., Liu Q., Maphalala G., Martinez E., Mathys V., Merker M., Miotto P., Mistry N., Moore D. A. J., Murray M., Niemann S., Omar S. V., Ong R. T.-H., Peto T. E. A., Posey J. E., Prammananan T., Pym A., Rodrigues C., Rodrigues M., Rodwell T., Rossolini G. M., Sánchez Padilla E., Schito M., Shen X., Shendure J., Sintchenko V., Sloutsky A., Smith E. G., Snyder M., Soetaert K., Starks A. M., Supply P., Suriyapol P., Tahseen S., Tang P., Teo Y.-Y., Thuong T. N. T., Thwaites G., Tortoli E., van Soolingen D., Walker A. S., Walker T. M., Wilcox M., Wilson D. J., Wyllie D., Yang Y., Zhang H., Zhao Y., et Zhu B.,

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing,
N. Engl. J. Med., vol. 379, no 15, p. 1403‑1415, nov. 2018. doi: 10.1056/NEJMoa1800474.

Chammartin F., Zürcher K., Keiser O., Weigel R., Chu K., Kiragga A. N., Ardura-Garcia C., Anderegg N., Laurent C., Cornell M., Tweya H., Haas A. D., Rice B. D., Geng E. H., Fox M. P., Hargreaves J. R., et Egger M.,
Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis,
Clin.Infect. Dis., vol. 67, no 11, p. 1643‑1652, nov. 2018. doi: 10.1093/cid/ciy347.

Imperial M. Z., Nahid P., Phillips P. P. J., Davies G. R., Fielding K., Hanna D., Hermann D., Wallis R. S., Johnson J. L., Lienhardt C., et Savic R. M.,
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis,
Nat. Med., vol. 24, no 11, p. 1708‑1715, nov. 2018. doi: 10.1038/s41591-018-0224-2.

Chesnais C.B., Nana-Djeunga H., Njamnshi A.K., Lenou-Nanga C.G., Boullé C., Zoung-Kanyi Bissek A.C., Kamgno J., Colebunders R. & Boussinesq M.
The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.
Lancet Infect Dis, vol. 18, no 11, p. 1278‑1286, nov. 2018. doi: 10.1016/S1473-3099(18)30425-0.

Cuzin L., Pugliese P., Katlama C., Bani-Sadr F., Ferry T., Rey D., Lourenco J., Bregigeon S., Allavena C., Reynes J., Cabié A., et Dat’AIDS Study Group,
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort,
J. Antimicrob. Chemother., déc. 2018. doi: 10.1093/jac/dky497.

Huerga H., Sanchez-Padilla E., Melikyan N., Atshemyan H., Hayrapetyan A., Ulumyan A., Bastard M., Khachatryan N., Hewison C., Varaine F., et Bonnet M.,
High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study,
Arch. Dis.Child., déc. 2018. doi: 10.1136/archdischild-2018-315411.

Penot P., Héma A., Bado G., Sombié D., Kaboré F. N., Poda A., Michon C., Terzolo O., Traoré A., Slama L., Sawadogo A., et Laurent C.,
Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship,
AIDS Care, vol. 30, no 12, p. 1502‑1506, déc. 2018. doi: 10.1080/09540121.2018.1497132.

De Nys H. M., Kingebeni P. M., Keita A. K., Butel C., Thaurignac G., Villabona-Arenas C.-J., Lemarcis T., Geraerts M., Vidal N., Esteban A., Bourgarel M., Roger F., Leendertz F., Diallo R., Ndimbo-Kumugo S.-P., Nsio-Mbeta J., Tagg N., Koivogui L., Toure A., Delaporte E., Ahuka-Mundeke S., Tamfum J.-J. M., Mpoudi-Ngole E., Ayouba A., et Peeters M.,
Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017,
Emerging Infectious Diseases, vol. 24, no 12, déc. 2018. doi: 10.3201/eid2412.180740.

Siewe Fodjo J. N., Tatah G., Tabah E. N., Ngarka L., Nfor L. N., Chokote S. E., Mengnjo M. K., Dema F., Sitouok A. T., Nkoro G., Ntone F. E., Bissek A.-C. Z.-K., Chesnais C. B., Boussinesq M., Colebunders R., et Njamnshi A. K.,
Epidemiology of Onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: Impact of more than 13 years of ivermectin.
Infect Dis Poverty, vol. 7, no 1, p. 114, déc. 2018. doi: 10.1186/s40249-018-0497-1.